Style | Citing Format |
---|---|
MLA | Pourakbari B, et al.. "Evaluation of the Quantiferon®-Tb Gold In-Tube Assay and Tuberculin Skin Test for the Diagnosis of Latent Tuberculosis Infection in an Iranian Referral Hospital." Infectious Disorders - Drug Targets, vol. 19, no. 2, 2019, pp. 141-144. |
APA | Pourakbari B, Yousefi K, Mahmoudi S, Sadeghi RH, Mamishi S (2019). Evaluation of the Quantiferon®-Tb Gold In-Tube Assay and Tuberculin Skin Test for the Diagnosis of Latent Tuberculosis Infection in an Iranian Referral Hospital. Infectious Disorders - Drug Targets, 19(2), 141-144. |
Chicago | Pourakbari B, Yousefi K, Mahmoudi S, Sadeghi RH, Mamishi S. "Evaluation of the Quantiferon®-Tb Gold In-Tube Assay and Tuberculin Skin Test for the Diagnosis of Latent Tuberculosis Infection in an Iranian Referral Hospital." Infectious Disorders - Drug Targets 19, no. 2 (2019): 141-144. |
Harvard | Pourakbari B et al. (2019) 'Evaluation of the Quantiferon®-Tb Gold In-Tube Assay and Tuberculin Skin Test for the Diagnosis of Latent Tuberculosis Infection in an Iranian Referral Hospital', Infectious Disorders - Drug Targets, 19(2), pp. 141-144. |
Vancouver | Pourakbari B, Yousefi K, Mahmoudi S, Sadeghi RH, Mamishi S. Evaluation of the Quantiferon®-Tb Gold In-Tube Assay and Tuberculin Skin Test for the Diagnosis of Latent Tuberculosis Infection in an Iranian Referral Hospital. Infectious Disorders - Drug Targets. 2019;19(2):141-144. |
BibTex | @article{ author = {Pourakbari B and Yousefi K and Mahmoudi S and Sadeghi RH and Mamishi S}, title = {Evaluation of the Quantiferon®-Tb Gold In-Tube Assay and Tuberculin Skin Test for the Diagnosis of Latent Tuberculosis Infection in an Iranian Referral Hospital}, journal = {Infectious Disorders - Drug Targets}, volume = {19}, number = {2}, pages = {141-144}, year = {2019} } |
RIS | TY - JOUR AU - Pourakbari B AU - Yousefi K AU - Mahmoudi S AU - Sadeghi RH AU - Mamishi S TI - Evaluation of the Quantiferon®-Tb Gold In-Tube Assay and Tuberculin Skin Test for the Diagnosis of Latent Tuberculosis Infection in an Iranian Referral Hospital JO - Infectious Disorders - Drug Targets VL - 19 IS - 2 SP - 141 EP - 144 PY - 2019 ER - |